CereGate is a startup based in Germany.
CereGate develops a minimally invasive Computer‑Brain Interface (CBI) technology to treat neurological disorders and restore sensory and motor functions. Its approach has been clinically tested in over 85 patients to address movement, balance, and sensory impairments.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.